Obigen Pharma Inc. (TPEX:7876)
Taiwan
· Delayed Price · Currency is TWD 35.65
-0.95 (-2.60%)
At close: Mar 9, 2026
Obigen Pharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 180.16 | 148.86 | 204.54 | 427.41 |
| Short-Term Investments | 473.7 | 608.7 | 739.3 | - |
| Cash & Short-Term Investments | 653.86 | 757.56 | 943.84 | 427.41 |
| Cash Growth | 52.98% | -19.74% | 120.83% | - |
| Other Receivables | 77.59 | 76.62 | 1.23 | 0.03 |
| Receivables | 77.59 | 76.62 | 1.23 | 0.03 |
| Prepaid Expenses | 16.57 | 3.68 | - | - |
| Other Current Assets | - | - | 71.48 | 63.73 |
| Total Current Assets | 748.01 | 837.87 | 1,017 | 491.17 |
| Property, Plant & Equipment | 239.31 | 274.37 | 312.79 | 303.34 |
| Other Intangible Assets | 647.79 | 668.82 | 707.2 | 748.43 |
| Other Long-Term Assets | 13.5 | 13.12 | 16.18 | 8.68 |
| Total Assets | 1,649 | 1,794 | 2,053 | 1,552 |
| Accrued Expenses | 9.8 | 17.28 | 7.11 | 3.55 |
| Current Portion of Leases | 14.94 | 14.8 | 13.77 | 6.73 |
| Other Current Liabilities | 5.74 | 5.29 | 3.17 | 6.78 |
| Total Current Liabilities | 30.48 | 37.37 | 24.05 | 17.06 |
| Long-Term Leases | 73.65 | 81.16 | 95.96 | 49.69 |
| Other Long-Term Liabilities | 0.55 | 0.55 | 0.56 | 0 |
| Total Liabilities | 104.69 | 119.08 | 120.57 | 66.75 |
| Common Stock | 1,060 | 1,060 | 1,060 | 760.03 |
| Additional Paid-In Capital | 1,492 | 1,488 | 1,470 | 770.43 |
| Retained Earnings | -1,009 | -872.71 | -598.41 | -353.11 |
| Comprehensive Income & Other | 0.24 | - | 0.24 | 307.53 |
| Shareholders' Equity | 1,544 | 1,675 | 1,932 | 1,485 |
| Total Liabilities & Equity | 1,649 | 1,794 | 2,053 | 1,552 |
| Total Debt | 88.59 | 95.96 | 109.73 | 56.42 |
| Net Cash (Debt) | 565.26 | 661.6 | 834.11 | 370.99 |
| Net Cash Growth | 52.36% | -20.68% | 124.83% | - |
| Net Cash Per Share | 5.33 | 6.24 | 8.14 | 4.88 |
| Filing Date Shares Outstanding | 106 | 106 | 106 | 76 |
| Total Common Shares Outstanding | 106 | 106 | 106 | 76 |
| Working Capital | 717.53 | 800.5 | 992.5 | 474.11 |
| Book Value Per Share | 14.56 | 15.80 | 18.23 | 19.54 |
| Tangible Book Value | 896.14 | 1,006 | 1,225 | 736.44 |
| Tangible Book Value Per Share | 8.45 | 9.49 | 11.56 | 9.69 |
| Machinery | 196.17 | 194.95 | 163.01 | 160.2 |
| Construction In Progress | - | - | 9.72 | 26.76 |
| Leasehold Improvements | 177.77 | 177.77 | 168.51 | 138.8 |
Source: S&P Capital IQ. Standard template. Financial Sources.